Evidence map›Paper›PMID 42249117›Full record

ArticleNature chemistry2026

Divergent and precise alkaloid remodelling with a small suite of reactions.

Shibo Xu, Harrison Judd, Xin Zhi Sui, Peng Liu, Amir H Hoveyda

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shibo XuDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, MA, USA.ORCID http://orcid.org/0000-0003-4003-3897
Harrison JuddDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, MA, USA.ORCID http://orcid.org/0009-0009-1300-0871
Xin Zhi SuiDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, MA, USA.
Peng LiuDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA. pengliu@pitt.edu.ORCID http://orcid.org/0000-0002-8188-632X
Amir H HoveydaDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, MA, USA. amir.hoveyda@bc.edu.ORCID http://orcid.org/0000-0002-1470-6456

Funding

U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health) GM-130395
6 · The paper itself

Abstract

Skeletally remoulded analogues of natural products enrich compound libraries, accelerating hit identification and drug discovery. Here we present a divergent alkaloid remodelling strategy that is centred on isolable platforms generated by Hofmann elimination. Piperidine deconstruction is thus effected through site-selective cleavage of a C-N σ-bond concomitant with the formation of a second alkene moiety. Ensuing alterations involving Stevens and/or Meisenheimer rearrangements and reconstruction by ring-closing metathesis or intramolecular hydroamination deliver expanded and contracted frameworks, respectively. By using a small selection of readily accessible catalysts and reagents, we prepared 26 altered frameworks in a total of 48 steps (~1.8 steps per reshaped structure). The utility of the approach is highlighted by the discovery of a reverse-Meisenheimer rearrangement and observation of a rare case of anionic [1,6]-sigmatropic rearrangement. In cellulo studies involving ten cancer cell lines reveal that an expanded amine-bridged and a deconstructed tricyclic framework exhibit micromolar and nanomolar activity, respectively.

Indexed as

AlkaloidsCell Line, TumorHumansMolecular StructureAlkaloids

Identifiers

PMID42249117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.